Clinical Trials Logo

Clinical Trial Summary

The actual COVID-19 epidemy is an unprecedented healthcare problem. Although acute respiratory distress syndrome is the main organ failure, acute kidney injury (AKI) has appeared to be more frequent and more severe than expected. Some data suggested a potential direct renal tropism of the virus, or undirect injury by "cytokine storm".

The aims of this study are:

1. To describe incidence, severity and mortality associated with AKI during covid-19 infection in ICU

2. To identify specific risk factors for AKI

3. To explore pathophysiologic mechanism of AKI during COVID-19 infection


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04459975
Study type Observational
Source Hospices Civils de Lyon
Contact Denis FOUQUE, Professor
Phone +33 472 678 704
Email denis.fouque@chu-lyon.fr
Status Recruiting
Phase
Start date April 1, 2020
Completion date November 2020